Study of Coagulation Faction VIIa Variant Marzeptacog Alfa (Activated) in Adult Subjects With Hemophilia

Clinical trial NCT04072237 · COMPLETED

Trial details

NCT number: NCT04072237
Sponsor: Catalyst Biosciences
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hemophilia A Hemophilia B Hemophilia A With Inhibitor Hemophilia B With Inhibitor Hemophilia A Without Inhibitor Hemophilia B Without Inhibitor

Start date: 2019-09-24
Primary completion: 2020-04-30
Enrollment: 11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.